AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS® FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING Market News
BriaCell Awarded National Cancer Institute Grant to Advance its Bria-OTS Immunotherapy for Cancer Geography
Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market Geography
C4 Therapeutics Announces FDA Clearance of Investigational New Drug Application for CFT8919, an Orally Bioavailable BiDAC Degrader Targeting EGFR L858R for Non-Small Cell Lung Cancer Market News
Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 p.m. EDT Pharmaceutical Investing
FDA Approves BriaCell's Pivotal Registrational Study Design in Advanced Metastatic Breast Cancer Pharmaceutical Investing
BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
